Alimera Sciencesの時価総額
Alimera Sciencesの時価総額は何ですか。
Alimera Sciences Inc.の時価総額は16.83M$です。
時価総額の定義は何ですか。
時価総額は、取引された会社の発行済株式の市場価値であり、一定期間のb株式に発行済株式数を掛けたものに等しい。
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
NASDAQのセクタHealth Careにおける時価総額の企業と比べるAlimera Sciences
Alimera Sciencesは何をしますか。
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Alimera Sciencesと類似の時価総額
- O2i SAの時価総額は16.79M$です。
- TNT Minesの時価総額は16.79M$です。
- Miliboo SAの時価総額は16.79M$です。
- e plcの時価総額は16.80M$です。
- K2 F&Bの時価総額は16.82M$です。
- TDH Incの時価総額は16.83M$です。
- Alimera Sciencesの時価総額は16.83M$です。
- Travel Technology Interactiveの時価総額は16.86M$です。
- Okapi Resourcesの時価総額は16.86M$です。
- Pantaflix AGの時価総額は16.87M$です。
- Applied Genetic Technologies Corpの時価総額は16.87M$です。
- Evgen Pharma plcの時価総額は16.87M$です。
- UPERGY Societe Anonymeの時価総額は16.88M$です。